Hospital
Chestnut Hill Hospital, LLC
Chestnut Hill Hospital, LLC was paid $9.52M by Medicaid between Aug 2019 and Aug 2023, across 130 billing codes. Its largest line is 99284, emergency room visit (serious) — 50% of everything it billed.
33Billing provider infoCHESTNUT HILL HOSPITAL, LLC
PHILADELPHIA, PA 19118
PHILADELPHIA, PA 19118
33aNPI1184148959assigned 08/02/2017
33bProvider typeGeneral Acute Care Hospital
28Total paid$9.52M
24GClaims108,380
24DCodes billed130
24AFirst – last monthAug 2019 – Aug 2023
Compared with peers
Next to other General Acute Care Hospital providers in Pennsylvania
Rank by total paid#35 of 154
Median peer was paid$2.82M
This provider vs. median3.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official CONNER, GARY controls 12+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 1,058 | $10K | |
| 2020 | 18,088 | $873K | |
| 2021 | 48,731 | $3.83M | |
| 2022 | 19,806 | $2.71M | |
| 2023 | 20,697 | $2.08M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 50% | 24,155 | 22,745 | $4.77M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 28% | 13,503 | 12,923 | $2.64M |
| G0378 | Hospital observation service, per hour | 3.4% | 387 | 339 | $327K |
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 2.6% | 1,152 | 339 | $247K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.3% | 1,476 | 1,381 | $221K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.4% | 461 | 455 | $133K |
| 76830 | Ultrasound, transvaginal | 1.2% | 372 | 367 | $110K |
| 73564 | 1.1% | 431 | 409 | $100K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 450 | 439 | $86K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 347 | 339 | $71K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,407 | 2,979 | $62K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,009 | 978 | $57K |
118 more codes
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 286 | $48K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,472 | $41K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,117 | $40K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,056 | $38K |
| 80053 | Comprehensive metabolic panel | <1% | 3,105 | $30K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 746 | $27K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 599 | $25K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,515 | $25K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 459 | $24K |
| 87631 | <1% | 509 | $22K | |
| 73630 | <1% | 305 | $21K | |
| 76642 | <1% | 112 | $19K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 56 | $19K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 7,461 | $18K |
| 73130 | <1% | 190 | $13K | |
| 73030 | <1% | 184 | $12K | |
| 77066 | Tomosynthesis, mammo | <1% | 39 | $12K |
| 73610 | <1% | 194 | $12K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 18 | $12K |
| 85027 | <1% | 255 | $12K | |
| 81025 | <1% | 1,996 | $11K | |
| 93971 | <1% | 68 | $10K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 473 | $9K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,825 | $9K |
| 84484 | <1% | 2,516 | $8K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 81 | $8K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 50 | $7K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 805 | $7K |
| 85610 | <1% | 734 | $7K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 15 | $7K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 455 | $7K |
| 77065 | Tomosynthesis, mammo | <1% | 28 | $7K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,280 | $7K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 896 | $6K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 100 | $6K |
| 82962 | <1% | 955 | $6K | |
| 73110 | <1% | 73 | $6K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 254 | $6K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 775 | $5K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 389 | $5K |
| 72100 | <1% | 90 | $5K | |
| 97161 | <1% | 36 | $5K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 816 | $4K |
| 87210 | <1% | 240 | $4K | |
| 85730 | <1% | 350 | $4K | |
| 0011A | <1% | 148 | $4K | |
| 86900 | <1% | 280 | $4K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 334 | $4K |
| 81001 | <1% | 1,719 | $4K | |
| 81003 | <1% | 680 | $3K | |
| 94060 | <1% | 14 | $3K | |
| 83735 | <1% | 1,486 | $3K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 108 | $3K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,317 | $3K |
| 0012A | <1% | 104 | $3K | |
| 73502 | <1% | 58 | $3K | |
| 83690 | <1% | 951 | $2K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 12 | $2K |
| 82248 | <1% | 454 | $2K | |
| 94726 | <1% | 14 | $2K | |
| 94729 | <1% | 13 | $2K | |
| 77062 | <1% | 24 | $1K | |
| 84702 | <1% | 117 | $1K | |
| 83605 | <1% | 391 | $1K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 49 | $1K |
| 83880 | <1% | 109 | $1K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 49 | $1K |
| 87077 | <1% | 144 | $1K | |
| 96376 | <1% | 176 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 133 | $1K |
| 85379 | <1% | 238 | $1K | |
| 87430 | <1% | 48 | $941.60 | |
| 90715 | <1% | 46 | $702.06 | |
| 73080 | <1% | 12 | $631.94 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 336 | $609.47 |
| 86850 | <1% | 146 | $606.36 | |
| 87040 | <1% | 64 | $477.68 | |
| 82550 | <1% | 206 | $458.17 | |
| 86901 | <1% | 219 | $458.03 | |
| J3490 | Unclassified drugs | <1% | 836 | $436.68 |
| 87186 | <1% | 125 | $430.08 | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 15 | $415.50 |
| 90686 | <1% | 42 | $370.13 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,911 | $348.85 |
| 84100 | <1% | 248 | $346.14 | |
| 82800 | <1% | 72 | $331.81 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,602 | $310.17 |
| G0008 | Administration of influenza virus vaccine | <1% | 47 | $221.21 |
| J2704 | Injection, propofol, 10 mg | <1% | 371 | $184.75 |
| 87081 | <1% | 42 | $156.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 501 | $141.82 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 634 | $132.86 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 440 | $108.07 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 104 | $104.80 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 461 | $100.80 |
| 36415 | Collection of venous blood by venipuncture | <1% | 30 | $95.20 |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 128 | $88.20 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 20 | $61.45 |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 52 | $47.10 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 320 | $40.01 |
| 87147 | <1% | 13 | $39.00 | |
| 87205 | <1% | 28 | $37.36 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 143 | $28.74 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 429 | $8.33 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 221 | $7.76 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 14 | $4.00 |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 0% | 68 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 93 | $0.00 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 0% | 178 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 85 | $0.00 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 0% | 25 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 30 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 30 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 27 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 57 | $0.00 |
| 00000 | 0% | 560 | $0.00 | |
| J2060 | Injection, lorazepam, 2 mg | 0% | 18 | $0.00 |
| J3480 | Injection, potassium chloride, per 2 meq | 0% | 33 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCONNER, GARY (VP & CFO)
| Provider | Location | Paid |
|---|---|---|
| Brandywine Hospital, LLC | Coatesville, PA | $2.97M |
| Jennersville Hospital, LLC | West Grove, PA | $1.35M |
| West Grove Clinic Company LLC | West Grove, PA | $157K |
| Tower Health Medical Group | Wyomissing, PA | $98K |
| Tower Health Medical Group | Wyomissing, PA | $84K |
| STC Pediatrics LLC | Philadelphia, PA | $24K |
| Tower Drexel Academic Medical Group LLC | Philadelphia, PA | $18K |
| Tower Health Urgent Care, LLC | Kennett Square, PA | $9K |
| Tower Health Urgent Care, LLC | Philadelphia, PA | $8K |
| Tower Health Urgent Care, LLC | Philadelphia, PA | $4K |
| Tower Health Urgent Care, LLC | Doylestown, PA | $3K |
| Tower Health Medical Group | West Reading, PA | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.